Annual CFI
$53.11 M
+$38.16 M+255.23%
December 31, 2023
Summary
- As of February 26, 2025, TARA annual cash flow from investing activities is $53.11 million, with the most recent change of +$38.16 million (+255.23%) on December 31, 2023.
- During the last 3 years, TARA annual CFI has risen by +$50.27 million (+1773.26%).
- TARA annual CFI is now at all-time high.
Performance
TARA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$29.39 M
-$32.34 M-1097.96%
September 30, 2024
Summary
- As of February 26, 2025, TARA quarterly cash flow from investing activities is -$29.39 million, with the most recent change of -$32.34 million (-1097.96%) on September 30, 2024.
- Over the past year, TARA quarterly CFI has dropped by -$35.77 million (-560.80%).
- TARA quarterly CFI is now -227.23% below its all-time high of $23.10 million, reached on March 31, 2024.
Performance
TARA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$11.17 M
-$35.77 M-76.20%
September 30, 2024
Summary
- As of February 26, 2025, TARA TTM cash flow from investing activities is $11.17 million, with the most recent change of -$35.77 million (-76.20%) on September 30, 2024.
- Over the past year, TARA TTM CFI has dropped by -$9.07 million (-44.81%).
- TARA TTM CFI is now -83.16% below its all-time high of $66.35 million, reached on March 31, 2024.
Performance
TARA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
TARA Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +255.2% | -560.8% | -44.8% |
| 3 y3 years | +1773.3% | -560.8% | -44.8% |
| 5 y5 years | +188.2% | -560.8% | -44.8% |
TARA Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +154.1% | -227.2% | at low | -83.2% | +111.4% |
| 5 y | 5-year | at high | +154.1% | -227.2% | +70.1% | -83.2% | +111.1% |
| alltime | all time | at high | +154.1% | -227.2% | +70.1% | -83.2% | +111.1% |
Protara Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$29.39 M(-1098.0%) | $11.17 M(-76.2%) |
| Jun 2024 | - | $2.94 M(-87.3%) | $46.94 M(-29.2%) |
| Mar 2024 | - | $23.10 M(+59.1%) | $66.35 M(+24.9%) |
| Dec 2023 | $53.11 M(+255.2%) | $14.52 M(+127.6%) | $53.11 M(+162.3%) |
| Sep 2023 | - | $6.38 M(-71.5%) | $20.24 M(-38.5%) |
| Jun 2023 | - | $22.35 M(+126.7%) | $32.91 M(+36.8%) |
| Mar 2023 | - | $9.86 M(-153.7%) | $24.07 M(+61.0%) |
| Dec 2022 | $14.95 M | -$18.34 M(-196.3%) | $14.95 M(-57.5%) |
| Sep 2022 | - | $19.05 M(+41.1%) | $35.18 M(+116.6%) |
| Jun 2022 | - | $13.50 M(+1712.3%) | $16.24 M(+1930.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $745.00 K(-60.6%) | $800.00 K(-100.8%) |
| Dec 2021 | -$98.19 M(-3563.6%) | $1.89 M(+1665.4%) | -$98.19 M(-2.4%) |
| Sep 2021 | - | $107.00 K(-105.5%) | -$100.59 M(-0.2%) |
| Jun 2021 | - | -$1.94 M(-98.0%) | -$100.83 M(+2.0%) |
| Mar 2021 | - | -$98.25 M(>+9900.0%) | -$98.89 M(-3588.0%) |
| Dec 2020 | $2.83 M(-696.8%) | -$511.00 K(+287.1%) | $2.83 M(-15.3%) |
| Sep 2020 | - | -$132.00 K(-2300.0%) | $3.35 M(-3.8%) |
| Jun 2020 | - | $6000.00(-99.8%) | $3.48 M(+0.2%) |
| Mar 2020 | - | $3.47 M | $3.47 M |
| Dec 2019 | -$475.00 K(-102.6%) | - | - |
| Dec 2018 | $18.43 M | - | - |
FAQ
- What is Protara Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Protara Therapeutics?
- What is Protara Therapeutics annual CFI year-on-year change?
- What is Protara Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Protara Therapeutics?
- What is Protara Therapeutics quarterly CFI year-on-year change?
- What is Protara Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Protara Therapeutics?
- What is Protara Therapeutics TTM CFI year-on-year change?
What is Protara Therapeutics annual cash flow from investing activities?
The current annual CFI of TARA is $53.11 M
What is the all time high annual CFI for Protara Therapeutics?
Protara Therapeutics all-time high annual cash flow from investing activities is $53.11 M
What is Protara Therapeutics annual CFI year-on-year change?
Over the past year, TARA annual cash flow from investing activities has changed by +$38.16 M (+255.23%)
What is Protara Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of TARA is -$29.39 M
What is the all time high quarterly CFI for Protara Therapeutics?
Protara Therapeutics all-time high quarterly cash flow from investing activities is $23.10 M
What is Protara Therapeutics quarterly CFI year-on-year change?
Over the past year, TARA quarterly cash flow from investing activities has changed by -$35.77 M (-560.80%)
What is Protara Therapeutics TTM cash flow from investing activities?
The current TTM CFI of TARA is $11.17 M
What is the all time high TTM CFI for Protara Therapeutics?
Protara Therapeutics all-time high TTM cash flow from investing activities is $66.35 M
What is Protara Therapeutics TTM CFI year-on-year change?
Over the past year, TARA TTM cash flow from investing activities has changed by -$9.07 M (-44.81%)